BACKGROUND: In recent years, breast cancer is the most common malignancy in women. The traditional method of surgery is to remove a woman's breast completely, which has a negative impact on her work and life. Today, women have a fiery pursuit to maintain their perfect figure, which has forced breast surgeon to find a new surgical approach to maintain the shape of the breast after surgery. METHODS: This study systematically analyzed and summarized the incision design and repair of glandular defects in early-stage breast cancer patients by oncoplastic breast techniques. By summarizing the methods of oncoplastic breast surgery (OBS) in different quadrants, it could help beginners to master this technology more quickly, so as to provide better help for breast cancer patients. RESULTS: A total of 216 breast cancer patients who underwent OBS from January 2016 to June 2020 at the Affiliated Hospital of Guangdong Medical University were included in this study. In patients treated with the volume-displacement method and the volume-replacement method, 92.6% and 86.2% of patients achieved excellent breast shape, respectively. CONCLUSIONS: OBS is a safe and effective way to treat early-stage breast cancer while obtaining better breast shape, reducing postoperative psychological trauma, and improving quality of life. 2021 Gland Surgery. All rights reserved.
BACKGROUND: In recent years, breast cancer is the most common malignancy in women. The traditional method of surgery is to remove a woman's breast completely, which has a negative impact on her work and life. Today, women have a fiery pursuit to maintain their perfect figure, which has forced breast surgeon to find a new surgical approach to maintain the shape of the breast after surgery. METHODS: This study systematically analyzed and summarized the incision design and repair of glandular defects in early-stage breast cancer patients by oncoplastic breast techniques. By summarizing the methods of oncoplastic breast surgery (OBS) in different quadrants, it could help beginners to master this technology more quickly, so as to provide better help for breast cancer patients. RESULTS: A total of 216 breast cancer patients who underwent OBS from January 2016 to June 2020 at the Affiliated Hospital of Guangdong Medical University were included in this study. In patients treated with the volume-displacement method and the volume-replacement method, 92.6% and 86.2% of patients achieved excellent breast shape, respectively. CONCLUSIONS: OBS is a safe and effective way to treat early-stage breast cancer while obtaining better breast shape, reducing postoperative psychological trauma, and improving quality of life. 2021 Gland Surgery. All rights reserved.
Entities:
Keywords:
Oncoplastic techniques; breast cancer; early-stage
Authors: Timothy J Whelan; Jim A Julian; Tanya S Berrang; Do-Hoon Kim; Isabelle Germain; Alan M Nichol; Mohamed Akra; Sophie Lavertu; Francois Germain; Anthony Fyles; Theresa Trotter; Francisco E Perera; Susan Balkwill; Susan Chafe; Thomas McGowan; Thierry Muanza; Wayne A Beckham; Boon H Chua; Chu Shu Gu; Mark N Levine; Ivo A Olivotto Journal: Lancet Date: 2019-12-05 Impact factor: 79.321
Authors: Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark Journal: N Engl J Med Date: 2002-10-17 Impact factor: 91.245
Authors: Benjamin D Smith; Douglas W Arthur; Thomas A Buchholz; Bruce G Haffty; Carol A Hahn; Patricia H Hardenbergh; Thomas B Julian; Lawrence B Marks; Dorin A Todor; Frank A Vicini; Timothy J Whelan; Julia White; Jennifer Y Wo; Jay R Harris Journal: Int J Radiat Oncol Biol Phys Date: 2009-07-15 Impact factor: 7.038
Authors: Conny Vrieling; Erik van Werkhoven; Philippe Maingon; Philip Poortmans; Caroline Weltens; Alain Fourquet; Dominic Schinagl; Bing Oei; Carla C Rodenhuis; Jean-Claude Horiot; Henk Struikmans; Erik Van Limbergen; Youlia Kirova; Paula Elkhuizen; Rudolf Bongartz; Raymond Miralbell; David A L Morgan; Jean-Bernard Dubois; Vincent Remouchamps; René-Olivier Mirimanoff; Guus Hart; Sandra Collette; Laurence Collette; Harry Bartelink Journal: JAMA Oncol Date: 2017-01-01 Impact factor: 31.777